Navigation Links
Verdict One Releases Directory of Board Certified Attorneys for Consumers
Date:9/13/2007

oard certified attorneys of all specialties, is in the business of revolutionizing the way consumers choose their lawyers, of promoting attorney specialty certification, and of providing attorneys with improved access to specialty referrals. The company is applying advanced information technology and business practices to achieve this goal.

The mission of Verdict One is to make board certification a national standard, making it possible for consumers to have improved assurance about their lawyer's experience, ethics and suitability to their problems. Contact Verdict One at http://www.VerdictOne.com.

Verdict One is a trademark of Verdict One, LLC.


'/>"/>
SOURCE Verdict One, LLC
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. President’s verdict: no need to panic over bird fl
2. Supreme Court Verdict Gives Hope to Striking Medicos
3. Supreme Court Verdict Gives Hope to Striking Medicos
4. Venugopal will not be Sacked Before Court Verdict: Central Government
5. Verdict Against Wyeth Pharma in Prempro Case
6. Sweet corn releases antioxidants on cooking
7. An International Growth Standard For Childs Releases By WHO
8. The National Governors Association Releases Guidelines For Outbreak Of Bird Flu
9. Eli Lilly Releases Digital Insulin Pen
10. DNA Directory Under Construction For Indian Criminals !
11. Canada: On Popular Demand, Tamiflu finds a Berth in the Directory of Patent Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...ire-USNewswire/ -- The University of Texas M. D....collaborative effort to eradicate breast cancer in...Awareness and Research of the Americas today at an...ed States, and Vivian Fernandez de Torrijos, the F...rson in the initiative are the U.S. Department of ...
(Date:11/21/2008)...PRNewswire-USNewswire/ -- U.S. News & World Re...nce (NCQA) ranked BlueChoice(R) HealthPlan of Sout...th Plans(TM), published in U.S. News & World R...annual ranking ranks the nation,s best health plan...nd NCQA accreditation scores. NCQA and U.S. News &...
(Date:11/21/2008)...gs do not cause genetic damage that can lead to di...s) -- Two popular medications for treating attenti...use genetic damage linked to an increased risk for...dy, done by researchers at Duke University Medical...nters a previous one that reported biomarkers asso...
(Date:11/21/2008)...swire/ -- For the second year in a row and the t...are Worldwide,s agency network won more creative a...nual international RX Club Show. , , Nine ...otal of 59 RX Club Awards of Excellence, including...are Worldwide agencies include Caudex Medical, ech...
Breaking Medicine News(10 mins):Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 3Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2Health News:ADHD Medications Don't Pose Cancer Risk 2Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 2Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 3Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 4
...arch UK survey reveals today. Over a quarter of Br...g the list over Alzheimer’s,// heart attack and te...s that the majority don’t realize approximately ho...ted by lifestyle factors. While two thirds of peop...
...roduced a bill (HR 1943) that would require federa... beginning and end of their// incarcerations, CQ H...ederal prisons to provide inmates with HIV/AIDS co... would receive access to comprehensive treatment. ...
...ody in the United Kingdom is suffering a stroke? I...kes could have been averted with// timely blood pr...ng one in four people due to undetected blood pres... Stroke Association studied blood pressure reading...
...tified the first patient-to-patient transmission o...rgery, despite standard infection// control proced...een published in the Journal of Infectious Disease...d an accompanying editorial say the case reinforce...
Other Medicine News:Health News:Survey Shows That Most People Unaware About Cancer Prevention 2Health News:Despite Control Efforts HBV Found to Transmit After Dental Surgery 2
(Date:11/20/2008)...swire-FirstCall/ -- Duska Therapeutics,Inc., (OT...as submitted its,pivotal Phase 3 ATPace clinical ...l Assessment (SPA) procedure with the U.S. Food an...securing an agreement with the FDA, Duska intends ...placebo-controlled and randomized Phase 3,clinica...
(Date:11/20/2008)...tCall/ -- PAREXEL International Corporation (Nasda...rvices provider, today announced that it has opene...nsulting and clinical research capabilities. With ...ocations throughout five important biopharmaceutic...gentina, Brazil, Chile, and Mexico. This expansion...
(Date:11/19/2008)...PRNewswire-FirstCall/ -- Amgen,(Nasdaq: AMGN ) ...sidiary of,Takeda Pharmaceutical Company Limited ...he Phase 3 MONET1 trial evaluating motesanib (AMG ...in for the first-line treatment of,advanced non-s... suspended,following a planned safety data review...
(Date:11/19/2008)...ewswire/ -- Biotech scientists increasingly are ap...h to better understand the effects of novel drug c...Genetic Engineering & Biotechnology News ( GE...t a new compound,s mechanism of action and eventua...according to the November 15 issue of GEN . ( htt...
Breaking Medicine Technology:Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7GEN Reports on the Trend Toward Predictive Toxicogenomics 2World Famous DavidBartonGym Buffs up the Bravern 12788 1World Famous DavidBartonGym Buffs up the Bravern 12788 2World Famous DavidBartonGym Buffs up the Bravern 12788 3Implementers Advocates Researchers Call on Congress to Honor Lantos Commitment to Public Health and Human Rights by Placing Evidence over Ideology 12785 1Implementers Advocates Researchers Call on Congress to Honor Lantos Commitment to Public Health and Human Rights by Placing Evidence over Ideology 12785 2Implementers Advocates Researchers Call on Congress to Honor Lantos Commitment to Public Health and Human Rights by Placing Evidence over Ideology 12785 3Implementers Advocates Researchers Call on Congress to Honor Lantos Commitment to Public Health and Human Rights by Placing Evidence over Ideology 12785 4Plexus Systems Inc Names Stosz to Solutions Engineer 12783 1Plexus Systems Inc Names Stosz to Solutions Engineer 12783 2Plexus Systems Inc Names Khanna to Senior Account Manager Western Region 12779 1Plexus Systems Inc Names Khanna to Senior Account Manager Western Region 12779 2
...INESS WIRE)--Apr 19, 2007 - Othera Pharmaceuticals...essor of,Pharmacology and Executive Vice President...tute at Albany College of Pharmacy,will present n...ombotic effect of Othera,s lead compound, OT-551, ... previous ocular,studies on OT-551 eye drops, as w...
..., April 19, 2007 /PRNewswire-FirstCall/ --,CuraGen...at,preliminary interim clinical data on intravenou...) inhibitor being investigated,for the treatment o...ming major medical meetings. , One oral and one po...lts with belinostat will be made at the 2007 Ameri...
Other Medicine Technology:Othera Pharmaceuticals Announces Upcoming Presentation Based Upon,Expanded Understanding of Lead Compound Mechanism of Action 2Othera Pharmaceuticals Announces Upcoming Presentation Based Upon,Expanded Understanding of Lead Compound Mechanism of Action 3Othera Pharmaceuticals Announces Upcoming Presentation Based Upon,Expanded Understanding of Lead Compound Mechanism of Action 4CuraGen and TopoTarget Announce New Clinical Results With,Belinostat to be Reported at Upcoming Major Medical Meetings 2CuraGen and TopoTarget Announce New Clinical Results With,Belinostat to be Reported at Upcoming Major Medical Meetings 3CuraGen and TopoTarget Announce New Clinical Results With,Belinostat to be Reported at Upcoming Major Medical Meetings 4CuraGen and TopoTarget Announce New Clinical Results With,Belinostat to be Reported at Upcoming Major Medical Meetings 5
Wet-Field Hemostatic Eraser bipolar tip, packsize is 5/box.
Sterile cordless eraser tips, packsize is 10/box.
Hydroview insertion forcep with very thin jaws to allow insertion through tunnel or clear cornea incision. Locking. Made in titanium.
Bi-angled insertion jaws designed to enhance surgeon comfort and efficiency. Reverse action releases lens when handle is compressed. Made in titanium.
Medicine Products: